The gout space is heating up, but is there sufficient room in the market to accommodate multiple new therapeutics?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009
Arthritis Research & Therapy Open Access 06 November 2013
-
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality
BMC Nephrology Open Access 29 July 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Kotz, J. The gout pipeline crystallizes. Nat Rev Drug Discov 11, 425–426 (2012). https://doi.org/10.1038/nrd3748
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3748
This article is cited by
-
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality
BMC Nephrology (2013)
-
Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009
Arthritis Research & Therapy (2013)
